AIS Healthcare Group is a global provider of outsourced clinical research services to the pharmaceutical and biotechnology industries. We have six decades of experience conducting Phase I-IV human research for clinical trials in more than 240 therapeutic areas. With a proven track record and industry-leading expertise, we offer our clients access to world-class research facilities with unmatched quality and regulatory compliance in more than 50 locations worldwide, 24/7 operational support, independent physician oversight, and efficient operational synergies that combine cost savings with an accelerated timeline for drug approval.
Because each clinical study is unique, our clients receive highly skilled insights and clinical resources from our industry-leading teams. To maintain the very highest standards of quality, we adhere to the most stringent global regulatory requirements, to maximize your research results. Our clinical partners are investigators who are respected leaders in their field. AIS Healthcare Group has maintained a track record of delivering fast-track drug approvals through Phase III and IV studies well in advance of competitors.
With our extensive global network and expertise, we continue to deliver on our commitment to excellence, regulatory compliance and speed to market. We are the leader in outsource clinical research services, bringing together the industry-leading teams to deliver proven results across therapeutic areas for a broad range of pharma clients.
Our experienced scientific team provides the most complete and current understanding of new drug development and their inherent risks. Our physicians meet with your investigators on an ongoing basis to provide the best advice for each phase of the study. We also maintain a strong working relationship with internal agencies for regulatory compliance.